Invention Grant
US09376396B2 Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor
有权
适用于治疗对多巴胺D3受体调节作用的疾病的酰氨基环烷基化合物
- Patent Title: Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor
- Patent Title (中): 适用于治疗对多巴胺D3受体调节作用的疾病的酰氨基环烷基化合物
-
Application No.: US14051626Application Date: 2013-10-11
-
Publication No.: US09376396B2Publication Date: 2016-06-28
- Inventor: Andreas Haupt , Jürgen Dinges , Liliane Unger , Karsten Wicke , Robert van Waterschoot , Scott Mittelstadt , Karla Drescher , Ana Relo
- Applicant: AbbVie Deutschland GmbH & Co. KG , AbbVie Inc.
- Applicant Address: DE Wiesbaden US IL North Chicago
- Assignee: ABBVIE DEUTSCHLAND GMBH & CO. KG,ABBVIE INC.
- Current Assignee: ABBVIE DEUTSCHLAND GMBH & CO. KG,ABBVIE INC.
- Current Assignee Address: DE Wiesbaden US IL North Chicago
- Agency: Neal, Gerber & Eisenberg LLP
- Main IPC: A61K31/496
- IPC: A61K31/496 ; C07D239/42 ; C07D403/04 ; C07D405/14 ; C07D239/26 ; C07D405/04
Abstract:
The present invention relates to novel acylaminocycloalkyl compounds, in particular to the compounds of the formula I as described herein and to their salts and N-oxides. The compounds possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of the dopamine D3 receptor.
Public/Granted literature
Information query
IPC分类:
